Skip to main content
Eyebrow Nav
  • Connect With Us
  • I'm a Patient
Home
Main navigation
  • About Narcolepsy
    • Pathophysiology
  • Screening & Diagnosis
    • Identifying Narcolepsy
    • Screeners
    • Diagnostic Criteria
    • Diagnostic Process
    • Diagnostic Challenges
  • Comorbidity Risk
    • Cardiovascular Comorbidities
    • Modifiable Risks for CV Disease
    • High Sodium Intake and CV Disease
    • Excess Sodium Intake Impact on Certain Body Systems
    • Psychiatric and Sleep Comorbidities
  • Disease Management
    • Management Considerations
  • Pediatric Patients
    • Burden of Illness
    • Symptoms
    • Clinical Interview
    • Differential Diagnosis
    • Screening
    • Patient and Caregiver Perspectives
  • Stay Connected
    • Connect With Us
    • Sleep Organizations
    • About NarcolepsyLink
  • Resources
    • Expert Clinical Insights
    • Clinical Resources
    • Narcolepsy FAQs
    • Glossary of Terms
Main navigation
  • About Narcolepsy
    • Pathophysiology
  • Screening & Diagnosis
    • Identifying Narcolepsy
    • Screeners
    • Diagnostic Criteria
    • Diagnostic Process
    • Diagnostic Challenges
  • Comorbidity Risk
    • Cardiovascular Comorbidities
    • Modifiable Risks for CV Disease
    • High Sodium Intake and CV Disease
    • Excess Sodium Intake Impact on Certain Body Systems
    • Psychiatric and Sleep Comorbidities
  • Disease Management
    • Management Considerations
  • Pediatric Patients
    • Burden of Illness
    • Symptoms
    • Clinical Interview
    • Differential Diagnosis
    • Screening
    • Patient and Caregiver Perspectives
  • Stay Connected
    • Connect With Us
    • Sleep Organizations
    • About NarcolepsyLink
  • Resources
    • Expert Clinical Insights
    • Clinical Resources
    • Narcolepsy FAQs
    • Glossary of Terms
  • Connect With Us
  • I'm a Patient

Epworth Sleepiness Scale for Children and Adolescents

Screen your pediatric patient for narcolepsy ESS-CHAD

ESS-CHAD

Download screening tools

The Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) is used to assess the level of excessive daytime sleepiness in children and adolescents.1,2 The ESS-CHAD is a modified version of the ESS that has been validated as a reliable measure of sleepiness in patients 12 to 18 years of age.1,2

Minor changes were made to the instructions and descriptions of some activities on the ESS to improve relatability and comprehension of the ESS-CHAD by children and adolescents.1

READ NEXT: Patient/Caregiver Perspectives

  1. Wang YG, Benmedjahed K, Lambert J, et al. Assessing narcolepsy with cataplexy in children and adolescents: development of a cataplexy diary and the ESS-CHAD. Nat Sci Sleep. 2017;9:201-211.
  2. Janssen KC, Phillipson S, O'Connor J, Johns MW. Validation of the Epworth Sleepiness Scale for Children and Adolescents using Rasch analysis. Sleep Med. 2017;33:30-35.
Image
Jazz Pharmaceuticals logo

Terms of Use

Connect With Us

Privacy Statement

Site Map

About NarcolepsyLink

NarcolepsyLink® is sponsored by Jazz Pharmaceuticals

©2026 Jazz Pharmaceuticals, Inc.

US-SLE-2100121 REV1224

You are now leaving NarcolepsyLink.com

Click "OK" to continue or "CANCEL" to return to
NarcolepsyLink.com.

Cancel OK

You are now leaving NarcolepsyLink.com

You will be directed to a website for a treatment option indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.

Cancel Continue

Are You a Healthcare Professional?

The information on the NarcolepsyLink website is intended for healthcare professionals only.

NO YES